Medical Devices Startups

Gate Bioscience develops small molecule therapeutics called Molecular Gates for disease treatment. The company operates in the drug discovery and development space.

3 investors

GCTx develops an induced pluripotent stem cell (iPSC) programming platform called TFome™ that uses synthetic biology, gene editing, and machine learning to improve cell therapy development and scaling. The platform is designed to expand patient access to cell therapies across various therapeutic areas.

3 investors

Gen1e builds healthcare solutions supported by a network of physicians across hospitals and medical centers.

3 investors

Genialis is a precision oncology company that applies data analysis to help drug developers understand mechanisms of action, resistance, and patient stratification for cancer therapies. It supports pharmaceutical partners in advancing molecules through clinical trials toward becoming effective medicines.

3 investors

Genomic Health develops diagnostic tests and related services and runs health-equity initiatives aimed at improving access, awareness, and outcomes for patients and communities, including uninsured and underinsured populations. The company focuses on making its tests inclusive through diverse clinical trials, patient education, and community partnerships.

3 investors

Getlabs provides at-home lab sample collection, sending phlebotomists to patients to draw blood and collect samples for lab tests ordered by their providers. Lab results are shared directly with the patient and the ordering provider, with support for connecting results to the Apple Health app.

3 investors

Neptune Medical designs and manufactures medical devices using proprietary Dynamic Rigidization technology that toggles thin-walled tubes between flexible and rigid states. Its flagship product, Pathfinder, is an FDA-cleared overtube for endoscopy procedures used in diagnostic and therapeutic GI endoscopy at U.S. hospitals and medical centers.

3 investors

GoCheck Kids offers a smartphone-based MultiScreener that combines photoscreening, visual acuity, and pure tone audiometry to screen young children for vision and hearing problems. Its technology is used by pediatric healthcare providers to detect risk factors for amblyopia and hearing loss early.

3 investors

Goodair makes Nosebuds, a reusable, drug-free nasal device worn inside the nostrils that uses small rotors to generate a vibroacoustic hum, stimulating nasal cilia to clear mucus and allergens and relieve congestion. It is marketed as a consumer wellness product for people with blocked nose, sinusitis, rhinitis, allergies, and colds, sold across New Zealand and Australia.

3 investors

Goryo Chemical develops fluorescence-based technology to visualize diseases and support diagnosis and treatment. The company applies chemistry to medical and healthcare applications for patients and clinicians.

3 investors

Healthy.io turns smartphone cameras into clinical-grade medical devices using colorimetric analysis, computer vision, and AI to let patients perform at-home urine tests and chronic wound assessments. It serves healthcare systems, insurers, and health plans, offering FDA-cleared and CE-marked products with EMR integration for early detection of conditions such as kidney disease.

3 investors

HeartLab provides a cloud-based platform that improves cardiology imaging workflows for medical teams. The platform enables remote collaboration and operational efficiency for cardiology clinicians and their patients.

3 investors

Hera Health Solutions is a biotechnology company that develops a proprietary nanotechnology platform to reformulate existing pharmaceutical compounds into more effective and longer-acting therapies. The platform enables rapid optimization of drugs with improved release profiles, reduced toxicity, and scalable manufacturing.

3 investors

HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis. The company focuses on cancer patients who have experienced treatment resistance through novel drug development approaches.

3 investors

Highridge Medical presents itself as a medical company built on a history of product innovation, led by an executive leadership team. The page does not detail specific products or services.

3 investors

HistoWiz provides digital pathology services including precision histology, immunostaining, slide archiving, and AI-powered image analysis for research and clinical laboratories. The company serves biomedical researchers, pharmaceutical companies, and diagnostic labs with automated histology processing and pathology consultation.

3 investors

HoustonBionics develops ExoRehab X, an exoskeletal rehabilitation device for stroke survivors to perform high-volume, patient-initiated repetitive movements at home. The device uses gamified exercises and lets clinicians track patient progress remotely to extend therapy beyond the clinic.

3 investors

Humacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform. Its off-the-shelf vessels target vascular trauma, AV access, and peripheral artery disease (PAD), and have received FDA Regenerative Medicine Advanced Therapy designation.

3 investors

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery. The company aims to restore damaged joints for patients undergoing surgical intervention.

3 investors

Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists. The company focuses on women's health and pelvic floor rehabilitation.

3 investors

Hyku Biosciences develops small molecule therapeutics with novel mechanisms of action designed to covalently bind non-cysteine amino acids and inactivate disease-driving proteins. The company operates in drug discovery, using its proprietary Hyku platform to address challenges such as selectivity, druggability, and resistance in disease targets.

3 investors

i-SENS is a global in-vitro diagnostics company that develops and manufactures blood glucose meters and point-of-care diagnostic devices such as electrolyte, blood gas, and HbA1c analyzers based on biosensor and electrochemical technology. Its products, including the continuous glucose monitor "CareSens Air," are sold in over 110 countries across Korea, the US, and Europe.

3 investors

iCardio.ai develops artificial intelligence software to automate the interpretation and analysis of echocardiogram ultrasound imaging for cardiologists. The company partners with ultrasound equipment manufacturers to deliver automated diagnostic and measurement tools to clinicians globally.

3 investors

iCHOR Vascular develops the iSWEEP system, an all-in-one combination thrombectomy and embolic protection device for peripheral vascular clot removal in both arteries and veins. The self-contained system uses a balloon sweep technique with an occlusion balloon, nitinol funnel guide catheter, and rapid exchange balloon catheter, targeting physicians treating vessels ranging from 4mm to 14mm.

3 investors